Sp1 is overexpressed in gastric cancer [42], in breast cancer [43], in thyroid tumors [44] and in pancreatic adenocarcinoma, Sp1 overexpression is associated with higher grade and lymph node metastasis [45]. Here, SP1 is linked to breast cancer.